Patients’ perspectives on a drug safety monitoring system for immune-mediated inflammatory diseases based on patient-reported outcomes

Published on Aug 12, 2021in Expert Opinion on Drug Safety3.383
· DOI :10.1080/14740338.2021.1963436
L. Kosse2
Estimated H-index: 2
,
G. Weits + 9 AuthorsEugène van Puijenbroek25
Estimated H-index: 25
Sources
Abstract
Patient-reported outcomes (PROs) on adverse drug reactions (ADRs) are increasingly used in cohort event monitoring (CEM) to obtain a better understanding of patients’ real-world experience with dru...
📖 Papers frequently viewed together
4 Citations
53 Citations
References0
Newest
Cited By0
Newest